This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Merck Patent Gesellschaft MIT Beschrankter Haftung, Merck Patent Gmbh. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,248 
1 out of 3,025 
Years Active: 2012-2014
Title: Djordje Musil: Innovator in Tumor Treatment
Introduction
Djordje Musil is a notable inventor based in Seeheim-Jugenheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for the treatment of tumors. With a total of 2 patents, his work has garnered attention in the scientific community.
Latest Patents
Djordje Musil's latest patents include innovative compounds that serve as inhibitors for various biological processes. One of his patents, titled "Pyrrolidinones as MetAP-2 inhibitors," focuses on compounds that inhibit methionine aminopeptidase, which can be employed for the treatment of tumors. Another significant patent is "5-cyanothienopyridines for the treatment of tumors," which presents novel 5-cyanothienopyridines that inhibit TGF-beta receptor kinase, also aimed at tumor treatment.
Career Highlights
Throughout his career, Djordje Musil has worked with prominent companies in the pharmaceutical industry. He has been associated with Merck Patent GmbH and Merck Patent Gesellschaft mit beschränkter Haftung, where he contributed to various research and development projects. His expertise in the field has allowed him to make impactful advancements in cancer treatment.
Collaborations
Djordje Musil has collaborated with esteemed colleagues such as Frank Zenke and Hartmut Greiner. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective research areas.
Conclusion
Djordje Musil's contributions to the field of pharmaceuticals, particularly in tumor treatment, highlight his role as an influential inventor. His patents reflect a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile